These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 26787703)

  • 1. Activity of Bisnaphthalimidopropyl Derivatives against Trypanosoma brucei.
    Graça NA; Gaspar L; Costa DM; Loureiro I; Thoo-Lin PK; Ramos I; Roura M; Pruvost A; Pemberton IK; Loukil H; MacDougall J; Tavares J; Cordeiro-da-Silva A
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2532-6. PubMed ID: 26787703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel pyrrolobenzoxaboroles: design, synthesis, and biological evaluation against Trypanosoma brucei.
    Wu P; Zhang J; Meng Q; Nare B; Jacobs RT; Zhou H
    Eur J Med Chem; 2014 Jun; 81():59-75. PubMed ID: 24826816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitrypanosomal activity of quaternary naphthalimide derivatives.
    Muth M; Hoerr V; Glaser M; Ponte-Sucre A; Moll H; Stich A; Holzgrabe U
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1590-3. PubMed ID: 17239596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trypanocidal activity of dicationic compounds related to pentamidine.
    Donkor IO; Assefa H; Rattendi D; Lane S; Vargas M; Goldberg B; Bacchi C
    Eur J Med Chem; 2001 Jun; 36(6):531-8. PubMed ID: 11525843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positively selected modifications in the pore of TbAQP2 allow pentamidine to enter
    Alghamdi AH; Munday JC; Campagnaro GD; Gurvic D; Svensson F; Okpara CE; Kumar A; Quintana J; Martin Abril ME; Milić P; Watson L; Paape D; Settimo L; Dimitriou A; Wielinska J; Smart G; Anderson LF; Woodley CM; Kelly SPY; Ibrahim HM; Hulpia F; Al-Salabi MI; Eze AA; Sprenger T; Teka IA; Gudin S; Weyand S; Field M; Dardonville C; Tidwell RR; Carrington M; O'Neill P; Boykin DW; Zachariae U; De Koning HP
    Elife; 2020 Aug; 9():. PubMed ID: 32762841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Vitro and In Vivo Investigation of the Inhibition of Trypanosoma brucei Cell Growth by Lipophilic Bisphosphonates.
    Yang G; Zhu W; Kim K; Byun SY; Choi G; Wang K; Cha JS; Cho HS; Oldfield E; No JH
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7530-9. PubMed ID: 26392508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 9- and 11-Substituted 4-azapaullones are potent and selective inhibitors of African trypanosoma.
    Maiwald F; Benítez D; Charquero D; Dar MA; Erdmann H; Preu L; Koch O; Hölscher C; Loaëc N; Meijer L; Comini MA; Kunick C
    Eur J Med Chem; 2014 Aug; 83():274-83. PubMed ID: 24973661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA binding affinity of bisguanidine and bis(2-aminoimidazoline) derivatives with in vivo antitrypanosomal activity.
    Dardonville C; Barrett MP; Brun R; Kaiser M; Tanious F; Wilson WD
    J Med Chem; 2006 Jun; 49(12):3748-52. PubMed ID: 16759117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationships for new organometallic complexes active against bloodstream forms of Trypanosoma brucei brucei.
    Loiseau PM; Gutierrez-Rios MT; De Frutos MI; Craciunescu DG
    Parasitol Res; 2001 Jul; 87(7):566-9. PubMed ID: 11484855
    [No Abstract]   [Full Text] [Related]  

  • 10. Bistacrines as potential antitrypanosomal agents.
    Schmidt I; Göllner S; Fuß A; Stich A; Kucharski A; Schirmeister T; Katzowitsch E; Bruhn H; Miliu A; Krauth-Siegel RL; Holzgrabe U
    Bioorg Med Chem; 2017 Aug; 25(16):4526-4531. PubMed ID: 28698054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chalcone-benzoxaborole hybrid molecules as potent antitrypanosomal agents.
    Qiao Z; Wang Q; Zhang F; Wang Z; Bowling T; Nare B; Jacobs RT; Zhang J; Ding D; Liu Y; Zhou H
    J Med Chem; 2012 Apr; 55(7):3553-7. PubMed ID: 22360533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trypanocidal activity of piperazine-linked bisbenzamidines and bisbenzamidoxime, an orally active prodrug.
    Huang TL; Bacchi CJ; Kode NR; Zhang Q; Wang G; Yartlet N; Rattendi D; Londono I; Mazumder L; Vanden Eynde JJ; Mayence A; Donkor IO
    Int J Antimicrob Agents; 2007 Dec; 30(6):555-61. PubMed ID: 17920820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substituted 2-phenylimidazopyridines: a new class of drug leads for human African trypanosomiasis.
    Tatipaka HB; Gillespie JR; Chatterjee AK; Norcross NR; Hulverson MA; Ranade RM; Nagendar P; Creason SA; McQueen J; Duster NA; Nagle A; Supek F; Molteni V; Wenzler T; Brun R; Glynne R; Buckner FS; Gelb MH
    J Med Chem; 2014 Feb; 57(3):828-35. PubMed ID: 24354316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacomodulations on new organometallic complexes of Ir, Pt, Rh, Pd, Os: in vitro and in vivo trypanocidal study against Trypanosoma brucei brucei.
    Loiseau PM; Craciunescu DG; Doadrio-Villarejo JC; Certad-Fombona G; Gayral P
    Trop Med Parasitol; 1992 Jun; 43(2):110-4. PubMed ID: 1519021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of Indoline-2-carboxamide Derivatives as a New Class of Brain-Penetrant Inhibitors of Trypanosoma brucei.
    Cleghorn LA; Albrecht S; Stojanovski L; Simeons FR; Norval S; Kime R; Collie IT; De Rycker M; Campbell L; Hallyburton I; Frearson JA; Wyatt PG; Read KD; Gilbert IH
    J Med Chem; 2015 Oct; 58(19):7695-706. PubMed ID: 26418485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of 2-(1H-imidazo-2-yl)piperazines as a new class of potent and non-cytotoxic inhibitors of Trypanosoma brucei growth in vitro.
    Ferrigno F; Biancofiore I; Malancona S; Ponzi S; Paonessa G; Graziani R; Bresciani A; Gennari N; Di Marco A; Kaiser M; Summa V; Harper S; Ontoria JM
    Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3689-3692. PubMed ID: 30482621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel S-adenosylmethionine decarboxylase inhibitors for the treatment of human African trypanosomiasis.
    Barker RH; Liu H; Hirth B; Celatka CA; Fitzpatrick R; Xiang Y; Willert EK; Phillips MA; Kaiser M; Bacchi CJ; Rodriguez A; Yarlett N; Klinger JD; Sybertz E
    Antimicrob Agents Chemother; 2009 May; 53(5):2052-8. PubMed ID: 19289530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A diminazene-resistant strain of Trypanosoma brucei brucei isolated from a dog is cross-resistant to pentamidine in experimentally infected albino rats.
    Anene BM; Ezeokonkwo RC; Mmesirionye TI; Tettey JN; Brock JM; Barrett MP; De Koning HP
    Parasitology; 2006 Jan; 132(Pt 1):127-33. PubMed ID: 16393361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics, Trypanosoma brucei gambiense efficacy, and time of drug action of DB829, a preclinical candidate for treatment of second-stage human African trypanosomiasis.
    Wenzler T; Yang S; Braissant O; Boykin DW; Brun R; Wang MZ
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5330-43. PubMed ID: 23959303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indirubin Analogues Inhibit
    Efstathiou A; Gaboriaud-Kolar N; Myrianthopoulos V; Vougogiannopoulou K; Subota I; Aicher S; Mikros E; Bastin P; Skaltsounis AL; Soteriadou K; Smirlis D
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30910902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.